UPDATE 4-Roche to buy U.S. biotech firm InterMune for $8.3 bln

* Consensus 2019 sales for InterMune lung drug $1.04 bln (Adds additional analyst comment, shares)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.